Biospecifics Technologies Corp (NASDAQ:BSTC)

39.95
Delayed Data
As of Feb 16
 +0.04 / +0.10%
Today’s Change
38.51
Today|||52-Week Range
58.79
-7.80%
Year-to-Date
Nektar (NKTR) Surges: Stock Moves 11% Higher
Feb 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close39.91
Today’s open39.69
Day’s range39.05 - 40.00
Volume32,091
Average volume (3 months)24,228
Market cap$287.2M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+18.18%
Earnings growth (this year)+0.64%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+15.39%
P/E ratio25.1
Price/Sales15.45
Price/Book5.08

Competitors

 Today’s
change
Today’s
% change
CLXTCalyxt Inc+0.26+1.18%
CDXSCodexis Inc+0.55+6.25%
ARWRArrowhead Pharmaceut...-0.26-4.46%
AVXLAnavex Life Sciences...+0.01+0.39%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)$0.39
Annual revenue (last year)$26.3M
Annual profit (last year)$11.4M
Net profit margin43.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Principal Financial Officer
Thomas L. Wegman
Corporate headquarters
Lynbrook, New York

Forecasts